Cullin 3 anticorps
-
- Antigène Voir toutes Cullin 3 (CUL3) Anticorps
- Cullin 3 (CUL3)
-
Reactivité
- Humain, Souris
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Cullin 3 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP)
- Specificité
- Reacts with the N-terminus part of human CUL3 / Cullin 3
- Réactivité croisée
- Souris
- Réactivité croisée (Details)
- Cross reacts with mouse protein.
- Purification
- Antiserum
- Immunogène
- Synthetic peptide from human CUL3 / Cullin 3.
- Isotype
- IgG
- Top Product
- Discover our top product CUL3 Anticorps primaire
-
-
- Indications d'application
-
Working dilution: ELISA (1:2000 - 1:10000), IHC-P (1:500), IP, WB (1:500 - 1:1000)
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 85 mg/mL
- Buffer
- , 0.01 % Sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C/-20 °C
- Stockage commentaire
- +4°C or -20°C, Avoid repeated freezing and thawing.
-
- Antigène
- Cullin 3 (CUL3)
- Autre désignation
- CUL3 / Cullin 3 (CUL3 Produits)
- Synonymes
- anticorps CUL-3, anticorps Cullin-3, anticorps CUL-3-A, anticorps Cullin-3-A, anticorps cul3, anticorps cul3a, anticorps CUL-3-B, anticorps Cullin-3-B, anticorps cul3b, anticorps wu:fc37e01, anticorps CUL3, anticorps ATCUL3, anticorps ATCUL3A, anticorps CUL3A, anticorps T24P13.25, anticorps cullin 3, anticorps cullin 3A, anticorps PHA2E, anticorps AI467304, anticorps AW146203, anticorps mKIAA0617, anticorps cullin 3, anticorps cullin 3 L homeolog, anticorps cullin 3 S homeolog, anticorps cullin-3, anticorps Cullin-3 (CUL-3), anticorps cullin 3a, anticorps CULlin, anticorps CUL3, anticorps cul3, anticorps cul3.L, anticorps cul3.S, anticorps PTRG_11586, anticorps Smp_117580, anticorps cul3a, anticorps Cul3, anticorps cul-3
- UniProt
- Q13618
- Pathways
- M Phase
-